Literature DB >> 35273687

Development and validation of a clinical model to predict hypertension in consecutive patients with obstructive sleep apnea hypopnea syndrome: a hospital-based study and nomogram analysis.

Xiangxia Zeng1, Danjie Ma1, Kang Wu1, Qifeng Yang1, Sun Zhang1, Yateng Luo1, Donghao Wang1, Yingying Ren2, Nuofu Zhang1.   

Abstract

BACKGROUND: To screen for risk predictors of hypertension in patients with Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) and develop and validate a clinical model for individualized prediction of hypertension in consecutive patients with OSAHS.
METHODS: 114 consecutive patients with OSAHS confirmed by PSG monitoring participated in this study. Those individuals were divided into two sets at a ratio of 7:3, using computer-generated random numbers: 82 individuals were assigned to the training set and 32 to the validation set. Important risk predictors of hypertension in individuals with OSAHS were confirmed using the LASSO method and a clinical nomogram constructed. The predictive accuracy was assessed by unadjusted concordance index (C-index) and calibration plot.
RESULTS: Univariate and multivariate regression analysis identified BMI, REM-AHI, REM-MSpO2 and T90% as predictive risk factors of OSAHS. Those risk factors were used to construct a clinical predictive nomogram. The calibration curves for hypertension in patients with OSAHS risk revealed excellent accuracy of the predictive nomogram model, internally and externally. The unadjusted concordance index (C-index) for the training and validation set was 0.897 [95% CI 0.795-0.912] and 0.894 [95% CI 0.788-0.820] respectively. The AUC of the training and validation set was 0.8175882 and 0.8031522, respectively. Decision curve analysis showed that the predictive model could be applied clinically when the threshold probability was 20 to 80%.
CONCLUSION: We constructed and validated a clinical nomogram to individually predict the occurrence of hypertension in patients with OSAHS. We determined that BMI, REM-AHI, REM-MSpO2 and T90% were independent risk predictors for hypertension in patients with OSAHS. This practical prognostic nomogram may help improve clinical decision making. AJTR
Copyright © 2022.

Entities:  

Keywords:  Obstructive sleep apnea hypopnea syndrome; clinical model; hypertension; risk predictors

Year:  2022        PMID: 35273687      PMCID: PMC8902532     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  29 in total

Review 1.  Relationship Between OSA and Hypertension.

Authors:  Gerard Torres; Manuel Sánchez-de-la-Torre; Ferran Barbé
Journal:  Chest       Date:  2015-09       Impact factor: 9.410

2.  Complement Components sC5b-9 and CH50 Predict Prognosis in Heart Failure Patients Combined With Hypertension.

Authors:  Wenyuan Wang; Dinghua Cai
Journal:  Am J Hypertens       Date:  2020-01-01       Impact factor: 2.689

Review 3.  Nomograms in oncology: more than meets the eye.

Authors:  Vinod P Balachandran; Mithat Gonen; J Joshua Smith; Ronald P DeMatteo
Journal:  Lancet Oncol       Date:  2015-04       Impact factor: 41.316

Review 4.  Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis.

Authors:  Adam V Benjafield; Najib T Ayas; Peter R Eastwood; Raphael Heinzer; Mary S M Ip; Mary J Morrell; Carlos M Nunez; Sanjay R Patel; Thomas Penzel; Jean-Louis Pépin; Paul E Peppard; Sanjeev Sinha; Sergio Tufik; Kate Valentine; Atul Malhotra
Journal:  Lancet Respir Med       Date:  2019-07-09       Impact factor: 30.700

5.  Predictors of Obstructive Sleep Apnea in Consecutive Patients with Metabolic Syndrome.

Authors:  Rodrigo P Pedrosa; Cristiane Maki-Nunes; Thiago Midlej-Brito; Heno F Lopes; Lunara S Freitas; Ivani C Trombetta; Edgar Toschi-Dias; Maria Janieire N N Alves; Raffael F Fraga; Maria U Rondon; Carlos E Negrão; Luiz A Bortolotto; Geraldo Lorenzi-Filho; Luciano F Drager
Journal:  Metab Syndr Relat Disord       Date:  2018-01-03       Impact factor: 1.894

6.  Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine.

Authors:  Richard B Berry; Rohit Budhiraja; Daniel J Gottlieb; David Gozal; Conrad Iber; Vishesh K Kapur; Carole L Marcus; Reena Mehra; Sairam Parthasarathy; Stuart F Quan; Susan Redline; Kingman P Strohl; Sally L Davidson Ward; Michelle M Tangredi
Journal:  J Clin Sleep Med       Date:  2012-10-15       Impact factor: 4.062

7.  OSA is common and independently associated with hypertension and increased arterial stiffness in consecutive perimenopausal women.

Authors:  Rodrigo P Pedrosa; Isly M L Barros; Luciano F Drager; Marcio S Bittencourt; Ana Kelley L Medeiros; Liana L Carvalho; Thais C Lustosa; Martinha M B Carvalho; Moacir N L Ferreira; Geraldo Lorenzi-Filho; Laura O B F Costa
Journal:  Chest       Date:  2014-07       Impact factor: 9.410

8.  Mild obstructive sleep apnea increases hypertension risk, challenging traditional severity classification.

Authors:  Izolde Bouloukaki; Ludger Grote; Walter T McNicholas; Jan Hedner; Johan Verbraecken; Gianfranco Parati; Carolina Lombardi; Ozen K Basoglu; Athanasia Pataka; Oreste Marrone; Paschalis Steiropoulos; Marisa R Bonsignore; Sophia E Schiza
Journal:  J Clin Sleep Med       Date:  2020-06-15       Impact factor: 4.062

Review 9.  Obstructive sleep apnea and insight into mechanisms of sympathetic overactivity.

Authors:  François Abboud; Ravinder Kumar
Journal:  J Clin Invest       Date:  2014-04-01       Impact factor: 14.808

10.  Association of Sleep Characteristics With Nocturnal Hypertension and Nondipping Blood Pressure in the CARDIA Study.

Authors:  S Justin Thomas; John N Booth; Byron C Jaeger; Demetria Hubbard; Swati Sakhuja; Marwah Abdalla; Donald M Lloyd-Jones; Daniel J Buysse; Core E Lewis; James M Shikany; Joseph E Schwartz; Daichi Shimbo; David Calhoun; Paul Muntner; Mercedes R Carnethon
Journal:  J Am Heart Assoc       Date:  2020-03-19       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.